These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 8024260

  • 1. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
    Meyerhoff DJ, MacKay S, Constans JM, Norman D, Van Dyke C, Fein G, Weiner MW.
    Ann Neurol; 1994 Jul; 36(1):40-7. PubMed ID: 8024260
    [Abstract] [Full Text] [Related]

  • 2. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [Abstract] [Full Text] [Related]

  • 3. Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease.
    Watanabe T, Shiino A, Akiguchi I.
    Dement Geriatr Cogn Disord; 2008 Dec; 26(1):89-100. PubMed ID: 18617735
    [Abstract] [Full Text] [Related]

  • 4. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.
    Husted CA, Goodin DS, Hugg JW, Maudsley AA, Tsuruda JS, de Bie SH, Fein G, Matson GB, Weiner MW.
    Ann Neurol; 1994 Aug; 36(2):157-65. PubMed ID: 8053651
    [Abstract] [Full Text] [Related]

  • 5. Axonal injury within language network in primary progressive aphasia.
    Catani M, Piccirilli M, Cherubini A, Tarducci R, Sciarma T, Gobbi G, Pelliccioli G, Petrillo SM, Senin U, Mecocci P.
    Ann Neurol; 2003 Feb; 53(2):242-7. PubMed ID: 12557292
    [Abstract] [Full Text] [Related]

  • 6. [1H-MR spectroscopic imaging in patients with clinically diagnosed Alzheimer's disease].
    Block W, Träber F, Kuhl CK, Fric M, Keller E, Lamerichs R, Rink H, Möller HJ, Schild HH.
    Rofo; 1995 Sep; 163(3):230-7. PubMed ID: 7548870
    [Abstract] [Full Text] [Related]

  • 7. An age and gender dependency of metabolite concentrations in basal ganglia in children with spastic diplegia: proton magnetic resonance spectroscopy study.
    Kulak W, Sobaniec W, Smigielska-Kuzia J, Kubas B, Zawada B, Otapowicz D.
    J Child Neurol; 2009 Jan; 24(1):73-9. PubMed ID: 18936194
    [Abstract] [Full Text] [Related]

  • 8. Magnetic resonance spectroscopic study of Alzheimer's disease and frontotemporal dementia/Pick complex.
    Mihara M, Hattori N, Abe K, Sakoda S, Sawada T.
    Neuroreport; 2006 Mar 20; 17(4):413-6. PubMed ID: 16514368
    [Abstract] [Full Text] [Related]

  • 9. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.
    Blasi G, Bertolino A, Brudaglio F, Sciota D, Altamura M, Antonucci N, Scarabino T, Weinberger DR, Nardini M.
    Psychiatry Res; 2004 Jul 30; 131(2):95-105. PubMed ID: 15313516
    [Abstract] [Full Text] [Related]

  • 10. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U, Lais C, Rochmont Adu M, Kratzsch T, Frölich L, Maurer K, Zanella FE, Lanfermann H, Pantel J.
    Psychiatry Res; 2009 Jul 15; 173(1):1-7. PubMed ID: 19427767
    [Abstract] [Full Text] [Related]

  • 11. Proton spectroscopy in Alzheimer's disease and cognitive impairment no dementia: a community-based study.
    Azevedo D, Tatsch M, Hototian SR, Bazzarella MC, Castro CC, Bottino CM.
    Dement Geriatr Cogn Disord; 2008 Jul 15; 25(6):491-500. PubMed ID: 18441524
    [Abstract] [Full Text] [Related]

  • 12. N-acetylaspartate/creatine and choline/creatine ratios in the thalami, insular cortex and white matter as markers of hypertension and cognitive impairment in the elderly.
    Ben Salem D, Walker PM, Bejot Y, Aho SL, Tavernier B, Rouaud O, Ricolfi F, Brunotte F.
    Hypertens Res; 2008 Oct 15; 31(10):1851-7. PubMed ID: 19015591
    [Abstract] [Full Text] [Related]

  • 13. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
    Chen CS, Chiang IC, Li CW, Lin WC, Lu CY, Hsieh TJ, Liu GC, Lin HF, Kuo YT.
    Psychiatry Res; 2009 Jun 30; 172(3):210-4. PubMed ID: 19303260
    [Abstract] [Full Text] [Related]

  • 14. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N, Ising M, Schreiber YA, Atiya M, Sonntag A, Auer DP.
    Neurosci Lett; 2009 Jun 30; 384(1-2):23-8. PubMed ID: 15905028
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
    Sahin I, Alkan A, Keskin L, Cikim A, Karakas HM, Firat AK, Sigirci A.
    J Diabetes Complications; 2008 Jun 30; 22(4):254-60. PubMed ID: 18413166
    [Abstract] [Full Text] [Related]

  • 16. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM, Gavrila D, Antúnez C, Tormo MJ, Salmerón D, Carles R, Jiménez Veiga J, Parrilla G, Torres del Río S, Fortuna L, Navarro C.
    Dement Geriatr Cogn Disord; 2008 Jun 30; 26(1):15-25. PubMed ID: 18566544
    [Abstract] [Full Text] [Related]

  • 17. Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging.
    Oh J, Pelletier D, Nelson SJ.
    Arch Neurol; 2004 Jul 30; 61(7):1081-6. PubMed ID: 15262739
    [Abstract] [Full Text] [Related]

  • 18. Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.
    Dubey P, Fatemi A, Barker PB, Degaonkar M, Troeger M, Zackowski K, Bastian A, Smith SA, Pomper MG, Moser HW, Raymond GV.
    Neurology; 2005 Jan 25; 64(2):304-10. PubMed ID: 15668429
    [Abstract] [Full Text] [Related]

  • 19. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.
    Arnold DL, Riess GT, Matthews PM, Francis GS, Collins DL, Wolfson C, Antel JP.
    Ann Neurol; 1994 Jul 25; 36(1):76-82. PubMed ID: 8024266
    [Abstract] [Full Text] [Related]

  • 20. Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T.
    Hetherington H, Kuzniecky R, Pan J, Mason G, Morawetz R, Harris C, Faught E, Vaughan T, Pohost G.
    Ann Neurol; 1995 Sep 25; 38(3):396-404. PubMed ID: 7668825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.